Ruxolitinib as an Effective Treatment for Hemophagocytic Lymphohistiocytosis Secondary to SARS-Cov-2 Infection: A Case Report

BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome. SARS-CoV-2 infection can induce secondary HLH, as described in previous case reports, but diagnosis and treatment are challenging. CASE STUDY: We described an older male patient diagnosed with HLH...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lina, Zhang, Xiaolin, Huang, Bo, Hou, Yue, Liu, Xinmin, Jiao, Hongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149062/
https://www.ncbi.nlm.nih.gov/pubmed/37131454
http://dx.doi.org/10.2147/IDR.S384035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149062/
https://www.ncbi.nlm.nih.gov/pubmed/37131454
http://dx.doi.org/10.2147/IDR.S384035

Ejemplares similares